<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>healthcare cost management &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/healthcare-cost-management/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Tue, 20 Oct 2026 08:55:11 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.1.3</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>healthcare cost management &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Research report: Reconfiguring clinical pharmacists’ roles under China’s DRG payment system: perspectives from clinical pharmacists and physicians in multidisciplinary teams</title>
		<link>https://bioengineer.org/research-report-reconfiguring-clinical-pharmacists-roles-under-chinas-drg-payment-system-perspectives-from-clinical-pharmacists-and-physicians-in-multidisciplinary-teams/</link>
		
		<dc:creator><![CDATA[]]></dc:creator>
		<pubDate>Tue, 20 Oct 2026 08:55:11 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[China]]></category>
		<category><![CDATA[Clinical]]></category>
		<category><![CDATA[clinical pharmacists]]></category>
		<category><![CDATA[DRG payment reform]]></category>
		<category><![CDATA[healthcare cost management]]></category>
		<category><![CDATA[hospital pharmacy]]></category>
		<category><![CDATA[Medication safety]]></category>
		<category><![CDATA[multidisciplinary teams]]></category>
		<category><![CDATA[pharmaceutical care]]></category>
		<category><![CDATA[pharmacists]]></category>
		<category><![CDATA[qualitative research]]></category>
		<category><![CDATA[Reconfiguring]]></category>
		<guid isPermaLink="false">https://bioengineer.org/?p=440080</guid>

					<description><![CDATA[A qualitative study in two Nanjing hospitals found that China’s DRG payment reform is expanding clinical pharmacists’ involvement in expenditure analysis and pathway design, while physicians still largely view them as medication advisers.]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">440080</post-id>	</item>
	</channel>
</rss>
